Astrazeneca Plc ADR (AZN)

Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.

5 Top Stock Trades for Thursday: MRNA, AZN, AAL, BYND, UNH

By Bret Kenwell, InvestorPlace Contributor Jul 15, 2020

Moderna, UnitedHeath, Beyond Meat, American Airlines and AstraZeneca were our top stock trades from Wednesday -- and here's why.

7 International Stocks to Buy as the World Economy Restarts

By Chris Lau, InvestorPlace Contributor Jul 2, 2020

These international stocks offer investors geographically diversified exposure and get a bigger bump as countries open up for business.

3 Top Healthcare Stocks for a More Aware World

By Faisal Humayun, InvestorPlace Contributor Jun 17, 2020

Even after the novel coronavirus is contained, healthcare stocks will remain in focus. Good time to accumulate stocks with strong growth outlook.

4 Top Stock Trades for Friday: NVDA, LULU, TJX, AZN

By Bret Kenwell, InvestorPlace Contributor May 21, 2020

Lululemon Athletica, Nvidia, TJX Companies and AstraZeneca were our top stock trades for Friday. That said, let's look at the charts.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

By Ian Cooper, InvestorPlace Contributor Feb 24, 2020

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

Amarin Has the Makings for a Gamechanging Product

By Tom Taulli, InvestorPlace Contributor Dec 13, 2019

Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.

New Sanofi CEO 2019: 8 Things to Know About Paul Hudson

By William White, InvestorPlace Writer Jun 7, 2019

There's a new Sanofi CEO preparing to join the company with current CEO Olivier Brandicourt retiring at the end of August.

Is AstraZeneca Stock Worth Buying Before Earnings?

By Nicolas Chahine, InvestorPlace Contributor Apr 10, 2019

AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.

3 Big Stock Charts for Monday: L Brands, Progressive and Packaging Corp. of America

By James Brumley, InvestorPlace Feature Writer Apr 1, 2019

The stock charts of PGR, LB and PKG are going to start the new trading week on the cusp of major moves that have been forming for weeks.

AstraZeneca News: Why AZN Stock Is Sliding Lower Today

By Karl Utermohlen, InvestorPlace Writer Mar 29, 2019

AstraZeneca announced that it has inked a deal with Daiichi Sankyo to improve its oncology branch. AZN stock is down more than 5% on Friday.

AstraZeneca Earnings: AZN Stock Zooms Higher on Q4 Beat

By William White, InvestorPlace Writer Feb 14, 2019

An AstraZeneca earnings beat for the pharmaceutical company's fourth quarter of 2018 has AZN stock heading higher on Thursday.

The 5 Best Dow Jones Stocks to Buy Now

By Aaron Levitt, InvestorPlace Contributor Jan 29, 2019

Don't ignore Dow Jones stocks. They can still power your portfolio. Here are 5 of the best to own in 2019 and beyond!

This Health Care Stock Could Pay Off Big

By Ken Trester Nov 9, 2018

Today I am recommending a bullish trade on AstraZeneca PLC (NYSE:AZN), a biopharmaceutical company focused on the development, discovery and commercialization of prescription medicines for a variety of diseases.